Purple Biotech Ltd. (PPBT)
Nasdaq: PPBT · Pharmaceutical Preparations · Rehovot, IL · filing with the SEC since 2014
Who runs Purple Biotech Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Efron Gil
Chief Executive Officer. First filing Mar 2026, latest Mar 31, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Efron Gil | Chief Executive Officer | Mar 2026 | Mar 31, 2026 | none |
| Lankry Shai S | Chief Financial Officer | Mar 2026 | Mar 30, 2026 | none |
| Schickler Michael | Head of Clinical & Reg Affairs | Mar 2026 | Mar 30, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Rock Simcha | director | Apr 2026 | Apr 17, 2026 | none |
| Zilberberg Suzana | director | Apr 2026 | Apr 7, 2026 | none |
| Agmon Ido | director | Apr 2026 | Apr 6, 2026 | none |
| Gagnon Robert E. | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.